NEBGH Members only, Webinar

Advances in Lung Cancer: Progress, Promise, and Workplace Support

Not a member and interested in attending? Contact Elizabeth Merrill.

Lung cancer continues to pose significant challenges as a leading cause of cancer-related deaths globally. However, advances in screening, biomarker testing, and treatment offer promising developments in the fight against this disease.  

Join us during Lung Cancer Awareness Month for an insightful webinar where we explore recent breakthroughs and discuss what employers can do to support their employees affected by lung cancer.

MSK Direct is a national, comprehensive employer benefits solution that provides equitable, personalized access to the lifesaving discoveries and subspecialized expertise of Memorial Sloan Kettering Cancer Center (MSK). Solely focused on cancer, MSK Direct supports employees and their families, wherever they live and at any stage of their cancer journey—ultimately improving health outcomes and lowering the cost of cancer care. 

Connect with MSK Direct to learn more: +1 (844) 557-5507 | | 

Featured Speaker

Jamie E. Chaft, MD

Thoracic Medical Oncologist
Memorial Sloan Kettering Cancer Center

I am a board-certified medical oncologist who specializes in caring for patients with lung cancer. 

I am part of a team of physicians from multiple disciplines — including thoracic surgery, radiation oncology, pathology, ​pulmonology, and interventional radiology — who meet weekly and collaborate to determine the optimal treatment plan for our patients. As part of our suite of treatment options, my colleagues and I run and participate in a multitude of clinical trials, all of which are available to patients who qualify and wish to participate. These trials range from therapeutic trials evaluating new treatment approaches to translational trials that help us learn more about lung cancer.

A thoracic oncologist is a cancer doctor with special training in thoracic (thor-A-sik) cancers. These are cancers that have to do with the chest, including lung, tracheal (windpipe), and thymic (thymus) cancers.


Dr. Mark Cunningham-Hill - Medical Director

Medical Director

Dr. Cunningham-Hill is an employee health expert known for his ability to create, identify and implement high-quality workplace health programs including prevention and screening, chronic illness interventions, and mental health and wellbeing initiatives. His broad occupational medicine and public health experience encompasses addressing chronic diseases impacting employers, employees and communities within the context of  social, cultural and racial determinants of health.

Mark has served as the Medical Director for Northeast Business Group on Health since early 2018. Until 2017, he served as Senior Director, Global Solutions Center and Head of Occupational Medicine at Johnson & Johnson, Inc . At J&J, Mark led a team of experts covering occupational medicine, health and wellness, personal energy management, EAP and mental wellbeing, and work-life effectiveness, and supported regional operational groups delivering health services to 135,000 employees in 120 companies. Prior to seven years at J&J, Mark spent 17 years at GlaxoSmithKline in both London and Philadelphia, including as Head of Global Operations, Employee Health Management.

Mark received his MB ChB, Bachelor of Medicine and Bachelor of Surgery at Manchester University in the UK. He is a Fellow of both the American College of Occupational & Environmental Medicine, and the Faculty of Occupational Medicine, London.